Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Mate Nemes
UBS
Mate Nemes
UBS
Wall Street Analyst
Not yet ranked — too few measurable calls.
100%
Success Rate
+13.3%
Average Return
2 of 2 calls profitable · +0.6% vs benchmark
🔒 3-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 100% of Mate Nemes's ratings turned a profit when each position was held for 1 year — averaging +13.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

36 Buy 9 Hold 0 Sell
Mate's Stock Coverage 18 ratings · 2026-06-21
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
GB:0NXR
Raiffeisen Bank International
 May 13, 2026 BUY Hold
-37.3% avg upside
9 analysts
$52.00
4.47% Downside
 ·
DE:DBK
Deutsche Bank AG
 Apr 29, 2026 BUY Buy
-25.3% avg upside
31 analysts
$34.00
9.21% Upside
 ·
DE:0B2
BAWAG Group AG
Apr 20, 2026 BUY Strong Buy
-28.0% avg upside
13 analysts
$156.00
9.05% Downside
 ·
EBKOF
Erste Group Bank
 Mar 12, 2026 BUY Strong Buy
-23.2% avg upside
15 analysts
$125.11
6.40% Downside
 +16.9%
OTPBF
OTP Bank Nyrt
 Mar 12, 2026 BUY Strong Buy
-26.5% avg upside
5 analysts
$145.35
0.87% Upside
 +9.6%
CH:VATN
Valiant Holding
 Feb 23, 2026 HOLD Sell
-5.2% avg upside
2 analysts
$168.00
5.46% Upside
 ·
CH:VONN
Vontobel Holding AG
 Feb 11, 2026 HOLD Hold
-5.0% avg upside
2 analysts
$71.00
1.19% Downside
 ·
CH:EFGN
EFG International AG
 Feb 04, 2026 HOLD Hold
+15.4% avg upside
2 analysts
$20.70
23.47% Upside
 ·
CH:PGHN
Partners Group Holding AG
 Jan 15, 2026 BUY Buy
+43.8% avg upside
10 analysts
$1297.00
90.48% Upside
 ·
CH:BAER
Julius Baer Group Ltd
 Nov 26, 2025 HOLD Strong Buy
+4.7% avg upside
15 analysts
$57.00
12.99% Downside
 ·
CH:CMBN
Cembra Money Bank AG
 Jul 28, 2025 HOLD Hold
-15.7% avg upside
3 analysts
$91.70
4.53% Downside
 ·
FR:GLE
Societe Generale
 Feb 10, 2025 BUY Strong Buy
-30.4% avg upside
17 analysts
$40.00
48.41% Downside
 ·
DE:CBK
Commerzbank
 Sep 26, 2024 BUY Buy
-36.1% avg upside
24 analysts
$18.20
52.54% Downside
 ·
FR:ACA
Credit Agricole
 Jan 04, 2024 HOLD Hold
-6.2% avg upside
12 analysts
$13.70
22.51% Downside
 ·
FR:BNP
BNP Paribas
 Jul 27, 2023 BUY Buy
-23.1% avg upside
21 analysts
$76.00
25.24% Downside
 ·
GB:BARC
Barclays
 Sep 03, 2020 BUY Strong Buy
-14.3% avg upside
13 analysts
$140.00
71.71% Downside
 ·
DE:5ZT
Piraeus Financial Holdings
 Jun 02, 2020 SELL Buy
+17.7% avg upside
5 analysts
$23.76
150.62% Upside
 ·
CH:GAM
GAM Holding AG
 Jan 20, 2020 HOLD Hold
+5899.9% avg upside
1 analyst
$4.20
5899.95% Upside
 ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Mate Nemes — Frequently Asked Questions
How accurate are Mate Nemes's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Mate's ratings were profitable over a one-year hold, with an average return of +13.3% per rating, or +0.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Mate ranked on 13Foresight?
Mate Nemes is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Mate cover?
Mate most recently has ratings on GB:0NXR, DE:DBK, DE:0B2, EBKOF, OTPBF, CH:VATN, CH:VONN, CH:EFGN, CH:PGHN, CH:BAER, CH:CMBN, FR:GLE and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.